Literature DB >> 24639

Inactivation of human gamma-glutamylcysteine synthetase by cystamine. Demonstration and quantification of enzyme-ligand complexes.

R V Lebo, N M Kredich.   

Abstract

Human erythrocyte gamma-glutamylcysteine synthetase is inactivated by the disulfide cystamine (2,2'-dithiobis-(ethylamine)) at pH 8.2 with a rate constant of 1020 min-1 mM-1. Magnesium ion and various combinations of substrates and products confer differing degrees of protection against cystamine inactivation, thus allowing the detection and quantification of certain enzyme-ligand interactions. By measuring inactivation rates as a function of ligand concentrations in incomplete reaction mixtures, we have obtained evidence for the following complexes: enzyme . Mg2+; enzyme . Mg2+ . MgATP2-; enzyme . Mg2+ . L-glutamate; enzyme . Mg2+ . MgATP2- . L-glutamate; enzyme . Mg2+ . L-gamma-glutamyl-L-alpha-aminobutyrate. The data also imply the existence of enzyme . (Mg2+)2 . MgATP2- . L-glutamate and several enzyme forms resulting from the weak binding to L-alpha-aminobutyrate. The methods used permit the calculation of cystamine inactivation rates for most of these enzyme forms and also give values for the equilibrium constants describing their formation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 24639

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.

Authors:  Marcus J Calkins; Jessica A Townsend; Delinda A Johnson; Jeffrey A Johnson
Journal:  Exp Neurol       Date:  2010-04-18       Impact factor: 5.330

2.  Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus.

Authors:  Gundula Min-Oo; Anny Fortin; Giuseppina Pitari; Mifong Tam; Mary M Stevenson; Philippe Gros
Journal:  J Exp Med       Date:  2007-02-20       Impact factor: 14.307

3.  Increase in proliferative markers after inhibition of transglutaminase.

Authors:  P J Birckbichler; G R Orr; M K Patterson; E Conway; H A Carter
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

4.  Identification of an important cysteine residue in human glutamate-cysteine ligase catalytic subunit by site-directed mutagenesis.

Authors:  Z Tu; M W Anders
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

5.  Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress.

Authors:  C Berruyer; F M Martin; R Castellano; A Macone; F Malergue; S Garrido-Urbani; V Millet; J Imbert; S Duprè; G Pitari; P Naquet; F Galland
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

6.  Vanin-1(-/-) mice show decreased NSAID- and Schistosoma-induced intestinal inflammation associated with higher glutathione stores.

Authors:  Florent Martin; Marie-France Penet; Fabrice Malergue; Hubert Lepidi; Alain Dessein; Franck Galland; Max de Reggi; Philippe Naquet; Bouchra Gharib
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  On the active site thiol of gamma-glutamylcysteine synthetase: relationships to catalysis, inhibition, and regulation.

Authors:  C S Huang; W R Moore; A Meister
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 8.  Toxicity of Glutathione-Binding Metals: A Review of Targets and Mechanisms.

Authors:  Federico Maria Rubino
Journal:  Toxics       Date:  2015-01-26

Review 9.  Vanin 1: Its Physiological Function and Role in Diseases.

Authors:  Roberta Bartucci; Anna Salvati; Peter Olinga; Ykelien L Boersma
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.